In the current study, we surveyed the anti-
Candida activity of the hydroalcoholic extracts of
H. persicum fruit against three different
Candida species (
C. albicans ,
C. tropicalis and
C. glabrata). The results are summarized in
Figure 1 and
Tables 1 and
2. The ethanolic and methanolic extracts of the tested plants showed anti-
Candida activities against
C. albicans (n = 29),
C. tropicalis (n = 10), and
C. glabrata (n = 7). The strongest activity was seen against
C. albicans with a range of 12 - 21 mm inhibition zones and 0.625 - 20 µg/µL MIC values; the ethanolic extract of the tested plant has more anti-
Candida effects at 0.625 µg/µL compared to the methanolic extract at 2.5 µg/µL. Similar results were reported by other researchers with different medicinal plants (
13). According to Mimica-Dukic et al. study (
14) among tested
Candida spp. isolates,
C. albicans was the most sensitive tested
Candida spp. to
Mentha piperita L. oil, which was in agreement with our results. The lowest concentration of the tested plant showed a potential anti-
Candida activity against
C. albicans and
C. glabrata , while the highest concentration showed a weak inhibitory effect against
C. tropicais . Furthermore, previous studies reported that the essential oil of
H. persicum has moderate anti-
Candida activity (
15). In Iranian traditional medicine,
H. persicum fruit was used as a carminative and pain relieving herbal drug (
16 ,
17 ). Review of literature reported that coumarins were known to be responsible for antifungal activity of many of the medicinal plants (
18,
19). It was suggested that furanocoumarins, isolated from the fruit of
H. persicum (
10), were the cause of anti-
Candida activity of this plant.
Candida species are in the normal flora of healthy people, while they can cause superficial mycosis and invasive infections in immunocompromised patients (
20). During the past 20 years, the incidence of infection by pathogenic fungi has been increased; most of which were infected by
Candida spp. that can change the superficial mycosis to invasive infections.
C. albicans has been a major factor of morbidity and mortality in immunocompromised patients, but other
Candida spp. such as
C. glabrata and
C. krusei have expanded in the recent years (
21 -
23).
Therefore, there is an urgent necessity for finding alternative antifungal drugs for effective treatment of Candidal infections.